Target intelligence / Profile preview

miR-3140-regulated oncogenic mRNAs (miR-3140 targets)

Target
miR-3140 targets
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

miR-3140-regulated oncogenic mRNAs refer to a group of messenger RNAs that are post-transcriptionally regulated by the microRNA miR-3140, particularly its mature form miR-3140-3p. This microRNA typically functions as a tumor suppressor by binding to the 3' untranslated regions (UTRs) or coding sequences of specific oncogenes, leading to their degradation or the inhibition of their translation (Yuan et al., 2016, PubMed: 26823710). Key validated targets include MAPK1 (also known as ERK2) and NRAS, which are central components of the mitogen-activated protein kinase (MAPK) signaling pathway (Uchino et al., 2013, PubMed: 23904689). In many cancers, miR-3140 is downregulated, leading to the overexpression of these oncogenic mRNAs and subsequent uncontrolled cell proliferation and survival. Therapeutic approaches focus on the use of miR-3140 mimics to restore normal regulation and suppress the expression of these oncogenic drivers. However, the complexity of miRNA targeting, including the potential to target genes like BRCA1, presents a challenge for clinical development due to potential context-dependent effects (Uchino et al., 2015, PubMed: 25672304). The interaction between miR-3140 and its targets remains a significant area of research for developing novel RNA-based therapeutics in oncology.

Other names
miR-3140-3p targetsMicroRNA-3140 targetsmiR-3140-3p/MAPK1 axismiR-3140-3p/NRAS axis
02

Mechanism of action

RNA interference-mediated degradation or translational repression of target oncogenic mRNAs

03

Biological functions

Gene silencingTranslation regulationCell proliferationSignal transductionApoptosis
04

Disease associations

CancerNon-small cell lung cancerBreast cancerColorectal cancer
05

Safety considerations

Off-target effects of miRNA mimics on non-target genesChallenges in the systemic delivery of RNA-based therapeutics to tumor sitesPotential suppression of tumor suppressor genes such as BRCA1 in specific cellular contexts
06

Interacting drugs

miR-3140-3p mimic
07

Biomarkers

miR-3140-3p expression levelsMAPK1 protein levelsNRAS protein levels

Beyond the preview

Go deeper on miR-3140-regulated oncogenic mRNAs (miR-3140 targets).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-3140-regulated oncogenic mRNAs (miR-3140 targets).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call